Monrovia, Liberia — The Ministry of Health has raised serious concerns over the widespread and unregulated sale and use of Misoprostol, commonly known by the brand name Cytotec, warning that the growing trend, particularly its unsupervised use for abortion, poses significant risks to public health across the country.
Misoprostol is a multi-purpose medication used for the prevention and treatment of stomach ulcers, as well as for reproductive health services, including the management of miscarriages, induction of labor, and abortion care. However, health experts caution that when used without proper medical supervision, especially in abortion-related cases outside approved medical settings, it can result in severe complications such as excessive bleeding, infections, and other life-threatening conditions.
The Ministry’s latest action comes amid increasing concerns within the health sector that the drug is being accessed and used outside regulated channels, prompting authorities to tighten control measures to prevent misuse and protect patients.
In a renewed effort to address the situation, the Ministry, in collaboration with key regulatory institutions, including the Liberia Medicines and Health Products Regulatory Authority (LMHRA), the Liberia Pharmacy Board (LPB), and the Liberia Medical and Dental Council (LMDC), has reaffirmed strict guidelines governing the distribution and use of the drug.
According to the health authorities, Misoprostol must only be issued or sold upon presentation of a valid prescription from a licensed physician or an authorized prescriber, in line with Liberian law. Additionally, the drug is to be dispensed strictly under the supervision of a licensed pharmacist or a qualified dispensing professional operating within a legally licensed medical or pharmaceutical facility.
The Ministry emphasized that these measures are critical to curbing misuse, including unauthorized or unsafe abortion practices carried out without proper medical oversight, which could endanger lives and strain the healthcare system.
As part of the reinforced regulatory framework, authorities have outlined a series of actions aimed at tightening oversight and ensuring compliance within the pharmaceutical sector. These include intensified monitoring of supply chains, routine inspection of pharmaceutical outlets, and verification of Misoprostol registration and distribution records.
Regulators will also ensure that pharmacies and pharmacists adhere to established dispensing protocols, including proper documentation and record-keeping practices. At the same time, efforts will be made to verify the credentials of prescribers, with disciplinary actions expected against any medical professional found issuing inappropriate or fraudulent prescriptions.
Furthermore, the Ministry and its partners have pledged to support ongoing investigations into the illegal distribution of Misoprostol and to take decisive action against individuals or entities engaged in criminal activities related to its sale.
Health authorities are urging the public and medical practitioners alike to comply with these regulations, stressing that responsible and medically supervised use of Misoprostol remains essential to safeguarding lives and maintaining the integrity of Liberia’s healthcare system.
